Literature DB >> 26833328

De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations.

Margot R F Reijnders1, Vasilios Zachariadis2, Brooke Latour3, Lachlan Jolly4, Grazia M Mancini5, Rolph Pfundt1, Ka Man Wu3, Conny M A van Ravenswaaij-Arts6, Hermine E Veenstra-Knol6, Britt-Marie M Anderlid7, Stephen A Wood8, Sau Wai Cheung9, Angela Barnicoat10, Frank Probst9, Pilar Magoulas9, Alice S Brooks5, Helena Malmgren7, Arja Harila-Saari11, Carlo M Marcelis1, Maaike Vreeburg12, Emma Hobson13, V Reid Sutton9, Zornitza Stark14, Julie Vogt15, Nicola Cooper16, Jiin Ying Lim17, Sue Price18, Angeline Hwei Meeng Lai17, Deepti Domingo19, Bruno Reversade20, Jozef Gecz4, Christian Gilissen1, Han G Brunner21, Usha Kini18, Ronald Roepman22, Ann Nordgren7, Tjitske Kleefstra23.   

Abstract

Mutations in more than a hundred genes have been reported to cause X-linked recessive intellectual disability (ID) mainly in males. In contrast, the number of identified X-linked genes in which de novo mutations specifically cause ID in females is limited. Here, we report 17 females with de novo loss-of-function mutations in USP9X, encoding a highly conserved deubiquitinating enzyme. The females in our study have a specific phenotype that includes ID/developmental delay (DD), characteristic facial features, short stature, and distinct congenital malformations comprising choanal atresia, anal abnormalities, post-axial polydactyly, heart defects, hypomastia, cleft palate/bifid uvula, progressive scoliosis, and structural brain abnormalities. Four females from our cohort were identified by targeted genetic testing because their phenotype was suggestive for USP9X mutations. In several females, pigment changes along Blaschko lines and body asymmetry were observed, which is probably related to differential (escape from) X-inactivation between tissues. Expression studies on both mRNA and protein level in affected-female-derived fibroblasts showed significant reduction of USP9X level, confirming the loss-of-function effect of the identified mutations. Given that some features of affected females are also reported in known ciliopathy syndromes, we examined the role of USP9X in the primary cilium and found that endogenous USP9X localizes along the length of the ciliary axoneme, indicating that its loss of function could indeed disrupt cilium-regulated processes. Absence of dysregulated ciliary parameters in affected female-derived fibroblasts, however, points toward spatiotemporal specificity of ciliary USP9X (dys-)function.
Copyright © 2016 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26833328      PMCID: PMC4746365          DOI: 10.1016/j.ajhg.2015.12.015

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  50 in total

1.  USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors.

Authors:  Lachlan A Jolly; Verdon Taylor; Stephen A Wood
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

2.  X-inactivation profile reveals extensive variability in X-linked gene expression in females.

Authors:  Laura Carrel; Huntington F Willard
Journal:  Nature       Date:  2005-03-17       Impact factor: 49.962

3.  Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes.

Authors:  Gaëlle Friocourt; Caroline Kappeler; Yoann Saillour; Fabien Fauchereau; Manuel S Rodriguez; Nadia Bahi; Marie-Claude Vinet; Philippe Chafey; Karine Poirier; Shinichiro Taya; Stephen A Wood; Catherine Dargemont; Fiona Francis; Jamel Chelly
Journal:  Mol Cell Neurosci       Date:  2005-01       Impact factor: 4.314

4.  Evolutionary and expression analysis of the zebrafish deubiquitylating enzyme, usp9.

Authors:  Poon-Yu Khut; Ben Tucker; Michael Lardelli; Stephen A Wood
Journal:  Zebrafish       Date:  2007       Impact factor: 1.985

5.  Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains.

Authors:  Abdallah K Al-Hakim; Anna Zagorska; Louise Chapman; Maria Deak; Mark Peggie; Dario R Alessi
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

6.  Centrioles in the cell cycle. I. Epithelial cells.

Authors:  I A Vorobjev
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

7.  The fat facets gene is required for Drosophila eye and embryo development.

Authors:  J A Fischer-Vize; G M Rubin; R Lehmann
Journal:  Development       Date:  1992-12       Impact factor: 6.868

8.  Clinical significance of de novo and inherited copy-number variation.

Authors:  Anneke T Vulto-van Silfhout; Jayne Y Hehir-Kwa; Bregje W M van Bon; Janneke H M Schuurs-Hoeijmakers; Stephen Meader; Claudia J M Hellebrekers; Ilse J M Thoonen; Arjan P M de Brouwer; Han G Brunner; Caleb Webber; Rolph Pfundt; Nicole de Leeuw; Bert B A de Vries
Journal:  Hum Mutat       Date:  2013-10-10       Impact factor: 4.878

9.  Seizures are regulated by ubiquitin-specific peptidase 9 X-linked (USP9X), a de-ubiquitinase.

Authors:  Lily Paemka; Vinit B Mahajan; Salleh N Ehaideb; Jessica M Skeie; Men Chee Tan; Shu Wu; Allison J Cox; Levi P Sowers; Jozef Gecz; Lachlan Jolly; Polly J Ferguson; Benjamin Darbro; Amy Schneider; Ingrid E Scheffer; Gemma L Carvill; Heather C Mefford; Hatem El-Shanti; Stephen A Wood; J Robert Manak; Alexander G Bassuk
Journal:  PLoS Genet       Date:  2015-03-12       Impact factor: 5.917

10.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

Authors:  H Hu; S A Haas; J Chelly; H Van Esch; M Raynaud; A P M de Brouwer; S Weinert; G Froyen; S G M Frints; F Laumonnier; T Zemojtel; M I Love; H Richard; A-K Emde; M Bienek; C Jensen; M Hambrock; U Fischer; C Langnick; M Feldkamp; W Wissink-Lindhout; N Lebrun; L Castelnau; J Rucci; R Montjean; O Dorseuil; P Billuart; T Stuhlmann; M Shaw; M A Corbett; A Gardner; S Willis-Owen; C Tan; K L Friend; S Belet; K E P van Roozendaal; M Jimenez-Pocquet; M-P Moizard; N Ronce; R Sun; S O'Keeffe; R Chenna; A van Bömmel; J Göke; A Hackett; M Field; L Christie; J Boyle; E Haan; J Nelson; G Turner; G Baynam; G Gillessen-Kaesbach; U Müller; D Steinberger; B Budny; M Badura-Stronka; A Latos-Bieleńska; L B Ousager; P Wieacker; G Rodríguez Criado; M-L Bondeson; G Annerén; A Dufke; M Cohen; L Van Maldergem; C Vincent-Delorme; B Echenne; B Simon-Bouy; T Kleefstra; M Willemsen; J-P Fryns; K Devriendt; R Ullmann; M Vingron; K Wrogemann; T F Wienker; A Tzschach; H van Bokhoven; J Gecz; T J Jentsch; W Chen; H-H Ropers; V M Kalscheuer
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

View more
  36 in total

1.  Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.

Authors:  Smitha Sripathy; Vid Leko; Robin L Adrianse; Taylor Loe; Eric J Foss; Emily Dalrymple; Uyen Lao; Tonibelle Gatbonton-Schwager; Kelly T Carter; Bernhard Payer; Patrick J Paddison; William M Grady; Jeannie T Lee; Marisa S Bartolomei; Antonio Bedalov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

Review 2.  Neurodevelopmental and Psychiatric Symptoms in Patients with a Cyst Compressing the Cerebellum: an Ongoing Enigma.

Authors:  Xavier Guell; Sheeba A Anteraper; Satrajit S Ghosh; John D E Gabrieli; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

Review 3.  When the Lyon(ized chromosome) roars: ongoing expression from an inactive X chromosome.

Authors:  Laura Carrel; Carolyn J Brown
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

4.  Understanding the Landscape of X-linked Variants Causing Intellectual Disability in Females Through Extreme X Chromosome Inactivation Skewing.

Authors:  Evelyn Quintanilha Vianna; Rafael Mina Piergiorge; Andressa Pereira Gonçalves; Jussara Mendonça Dos Santos; Veluma Calassara; Carla Rosenberg; Ana Cristina Victorino Krepischi; Raquel Tavares Boy da Silva; Suely Rodrigues Dos Santos; Márcia Gonçalves Ribeiro; Filipe Brum Machado; Enrique Medina-Acosta; Márcia Mattos Gonçalves Pimentel; Cíntia Barros Santos-Rebouças
Journal:  Mol Neurobiol       Date:  2020-06-20       Impact factor: 5.590

5.  Gonadal mosaicism of a novel IQSEC2 variant causing female limited intellectual disability and epilepsy.

Authors:  Lisa J Ewans; Michael Field; Ying Zhu; Gillian Turner; Melanie Leffler; Marcel E Dinger; Mark J Cowley; Michael F Buckley; Ingrid E Scheffer; Matilda R Jackson; Tony Roscioli; Cheryl Shoubridge
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

6.  Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.

Authors:  Omer Schwartzman; Angela Maria Savino; Michael Gombert; Chiara Palmi; Gunnar Cario; Martin Schrappe; Cornelia Eckert; Arend von Stackelberg; Jin-Yan Huang; Michal Hameiri-Grossman; Smadar Avigad; Geertruy Te Kronnie; Ifat Geron; Yehudit Birger; Avigail Rein; Giulia Zarfati; Ute Fischer; Zohar Mukamel; Martin Stanulla; Andrea Biondi; Giovanni Cazzaniga; Amedeo Vetere; Bridget K Wagner; Zhu Chen; Sai-Juan Chen; Amos Tanay; Arndt Borkhardt; Shai Izraeli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

7.  Usp9X Controls Ankyrin-Repeat Domain Protein Homeostasis during Dendritic Spine Development.

Authors:  Sehyoun Yoon; Euan Parnell; Maria Kasherman; Marc P Forrest; Kristoffer Myczek; Susitha Premarathne; Michelle C Sanchez Vega; Michael Piper; Thomas H J Burne; Lachlan A Jolly; Stephen A Wood; Peter Penzes
Journal:  Neuron       Date:  2019-12-05       Impact factor: 17.173

8.  Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.

Authors:  Tychele N Turner; Amy B Wilfert; Trygve E Bakken; Raphael A Bernier; Micah R Pepper; Zhancheng Zhang; Rebecca I Torene; Kyle Retterer; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2019-11-27       Impact factor: 11.025

9.  Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.

Authors:  Brett V Johnson; Raman Kumar; Sabrina Oishi; Suzy Alexander; Maria Kasherman; Michelle Sanchez Vega; Atma Ivancevic; Alison Gardner; Deepti Domingo; Mark Corbett; Euan Parnell; Sehyoun Yoon; Tracey Oh; Matthew Lines; Henrietta Lefroy; Usha Kini; Margot Van Allen; Sabine Grønborg; Sandra Mercier; Sébastien Küry; Stéphane Bézieau; Laurent Pasquier; Martine Raynaud; Alexandra Afenjar; Thierry Billette de Villemeur; Boris Keren; Julie Désir; Lionel Van Maldergem; Martina Marangoni; Nicola Dikow; David A Koolen; Peter M VanHasselt; Marjan Weiss; Petra Zwijnenburg; Joaquim Sa; Claudia Falcao Reis; Carlos López-Otín; Olaya Santiago-Fernández; Alberto Fernández-Jaén; Anita Rauch; Katharina Steindl; Pascal Joset; Amy Goldstein; Suneeta Madan-Khetarpal; Elena Infante; Elaine Zackai; Carey Mcdougall; Vinodh Narayanan; Keri Ramsey; Saadet Mercimek-Andrews; Loren Pena; Vandana Shashi; Kelly Schoch; Jennifer A Sullivan; Filippo Pinto E Vairo; Pavel N Pichurin; Sarah A Ewing; Sarah S Barnett; Eric W Klee; M Scott Perry; Mary Kay Koenig; Catherine E Keegan; Jane L Schuette; Stephanie Asher; Yezmin Perilla-Young; Laurie D Smith; Jill A Rosenfeld; Elizabeth Bhoj; Paige Kaplan; Dong Li; Renske Oegema; Ellen van Binsbergen; Bert van der Zwaag; Marie Falkenberg Smeland; Ioana Cutcutache; Matthew Page; Martin Armstrong; Angela E Lin; Marcie A Steeves; Nicolette den Hollander; Mariëtte J V Hoffer; Margot R F Reijnders; Serwet Demirdas; Daniel C Koboldt; Dennis Bartholomew; Theresa Mihalic Mosher; Scott E Hickey; Christine Shieh; Pedro A Sanchez-Lara; John M Graham; Kamer Tezcan; G B Schaefer; Noelle R Danylchuk; Alexander Asamoah; Kelly E Jackson; Naomi Yachelevich; Margaret Au; Luis A Pérez-Jurado; Tjitske Kleefstra; Peter Penzes; Stephen A Wood; Thomas Burne; Tyler Mark Pierson; Michael Piper; Jozef Gécz; Lachlan A Jolly
Journal:  Biol Psychiatry       Date:  2019-06-29       Impact factor: 13.382

10.  Experiences with offering pro bono medical genetics services in the West Indies: Benefits to patients, physicians, and the community.

Authors:  Andrew K Sobering; Dong Li; Jennifer S Beighley; John C Carey; Tyhiesia Donald; Sarah H Elsea; Karla P Figueroa; Jennifer Gerdts; Andre Hamlet; Ghayda M Mirzaa; Beverly Nelson; Stefan M Pulst; Janice L Smith; Flora Tassone; Helga V Toriello; Ruth H Walker; Katherine R Yearwood; Elizabeth J Bhoj
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-12-04       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.